CHM 11.1% 2.0¢ chimeric therapeutics limited

The article seems to be about a trial to treat multiple Myeloma...

  1. 74 Posts.
    lightbulb Created with Sketch. 5
    The article seems to be about a trial to treat multiple Myeloma rather than solid cancers, but the treatment uses CAR T-cell technology which sounds similar to my totally uneducated ears. I believe the company in question is a US one, but this trial is to take place in Australia.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(11.1%)
Mkt cap ! $17.25M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $26.18K 1.372M

Buyers (Bids)

No. Vol. Price($)
7 736556 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1462067 5
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.